Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities
Arthritis & Rheumatology · 2025-12 · 77 (12) · 1626-1634
DOI: 10.1002/art.43258 ↗Kurz gefasst
Fallbericht in der Zeitschrift Arthritis & Rheumatology, online erschienen am 27.07.2025. Verfasst von Thalia G Newman und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan Medical School, Ann Arbor. Hauptthemen laut MEDLINE: Antibodies, Antiphospholipid, Antiphospholipid Syndrome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory disease characterized by vascular thrombosis, pregnancy morbidity, and other manifestations driven by antiphospholipid autoantibodies. In this review, we present a clinical case that illustrates some diagnostic and therapeutic challenges in managing severe, relapsing APS manifestations, including microvascular injury and diffuse alveolar hemorrhage. We then discuss recent advances in our understanding of APS pathophysiology, emphasizing the critical role of anti–β‐2 glycoprotein I antibodies in triggering cell‐specific inflammatory and thrombotic pathways. Finally, we speculate that achieving definitive disease control will ultimately require strategies that eliminate or effectively neutralize these pathogenic antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Michigan Medical School, Ann Arbor.
ORCID-Profile: Jason S Knight
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Newman, T. G., & Knight, J. S. (2025). Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities. Arthritis & Rheumatology, 77(12), 1626-1634. https://doi.org/10.1002/art.43258
Vancouver
Newman TG, Knight JS. Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities. Arthritis & Rheumatology. 2025;77(12):1626-1634. doi:10.1002/art.43258
BibTeX
@article{Newman2025,
author = {Newman, Thalia G and Knight, Jason S},
title = {Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities},
journal = {Arthritis & Rheumatology},
year = {2025},
volume = {77},
number = {12},
pages = {1626--1634},
doi = {10.1002/art.43258}
}
EUVIMED